Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $284,050 - $338,474
2,500 New
2,500 $325,000
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $244,480 - $308,256
3,200 New
3,200 $301,000
Q3 2023

Nov 15, 2023

BUY
$69.23 - $79.09 $484,610 - $553,630
7,000 New
7,000 $526,000
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $4,433 - $5,782
100 Added 1.12%
9,000 $516,000
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $628,212 - $889,044
-15,600 Reduced 63.67%
8,900 $408,000
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $1.16 Million - $2.06 Million
24,500 New
24,500 $1.2 Million
Q2 2021

Aug 06, 2021

SELL
$73.06 - $97.7 $496,808 - $664,360
-6,800 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$70.43 - $97.42 $42,258 - $58,452
-600 Reduced 8.11%
6,800 $574,000
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $63,570 - $97,838
1,300 Added 21.31%
7,400 $553,000
Q3 2020

Nov 13, 2020

BUY
$37.23 - $50.97 $227,102 - $310,917
6,100 New
6,100 $311,000
Q2 2019

Aug 20, 2019

SELL
$63.59 - $78.71 $476,925 - $590,325
-7,500 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$50.75 - $80.54 $15,225 - $24,162
-300 Reduced 3.85%
7,500 $588,000
Q4 2018

Feb 14, 2019

SELL
$52.18 - $67.93 $500,928 - $652,128
-9,600 Reduced 55.17%
7,800 $435,000
Q3 2018

Nov 14, 2018

SELL
$38.13 - $68.37 $160,146 - $287,154
-4,200 Reduced 19.44%
17,400 $1.13 Million
Q1 2018

May 15, 2018

BUY
$26.05 - $34.5 $562,680 - $745,200
21,600 New
21,600 $666,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.85B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.